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T he third annual meeting of the Photomedicine Soci-ety was held in conjunction with the annual meeting of the American Society for Photobiology on June 28, 1994, in Scottsdale, Arizona. A total of 17 abstracts were presented; attendees included derma-
tologists and photobiologists. 
The first part of the meeting was on photoimmunology. S. Grabbe 
(Munster, Germany) showed that in contrast to ill vitro fu,dings, 
application of antigen through ultraviolet B (UVB)-irradiated skin of 
Balbi c mice was not sufficient to induce tolerance in sensitized 
animals; the discrepancy between these ill lIitro and it/. I,ivo results needs 
to be further investigated. F. Noonan (Washington, D.C.) showed 
that the trait for susceptibility to UV suppression in mice was con-
trolled by three interacting genes, two autosomal and one X-linked. L. 
Roberts (Memphis, TN) demonstrated that SWl protection factor 
(SPF)-15 and SPF-30 commercial sunscreen lotions prevented tumor-
inmlune suppression in C3H mice exposed to UV energy similar to 
that of the solar spectrum; the light sources used were Kodacel-filtered 
FS lamps and solar simulator, which did not emit radiation less than 
290 nm. The different light sources used may explain the discrepancy 
in the results of this study and those of a previously reported study that 
showed a lack of efficacy of sunscreens in the prevention of UV-
induced immunosuppression. A. Vink (Houston, TX) reported that in 
C3H mice, la-positive, cyclobutane pyrimidine dimer-containing cells 
could be detected in the draining lymph nodes 4 d following a single 
dose of UVB irradiation . Similar findings were observed in SCID 
mice, suggesting that these cells were not T or B cells. P. Cruz (Dallas, 
TX) investigated the effect ofVVB and LPS in macrophages obtained 
from C3H/HeJ and C3H/HeN mice, differing only in the mutation of 
LpSd gene controlli.ng responsiveness to LPS. It was found that the 
mechanisms ofUVB and LPS-induced cytokine production were not 
identical, and that UVB could amplify the outcome of the LPS-
dependent pathway, possibly by releasing the translational block in 
cytokine biosynthesis conferred by the LpSd mutation. A. J eevan 
(Houston, TX) reported that following UVB radiation of C3H mouse 
macrophages, the ability of these cells to kill intracellular bacteria and 
to generate nitric oxide were impaired, which may contribute to the 
impaired clearance of bacteria seen ill lIillo. 
The next part of the meeting was on clinical photodermatology. 
H. Lim (New York, NY) presented results of evaluation of the 
photosensitivity disorder in 203 patients, showing that polymor-
phous light eruption (26%) and chronic actinic dermatitis (170;',) 
were the most commonly made diagnosis; sunscreens, fragrances, 
and antimicrobials were the most common photoallergens. 
M . Sanchez (New York, NY), in a study involving 57 HIV-
positive patients and 57 matched controls, reported that the mean 
minimal erythema dose to UVB of HIV -infected patients was not 
different from that of control group, indicating that HIV-positive 
individuals were not sensitive to UVB . T. Meola (New York, NY) 
reported that UVB phototherapy was an effective therapy for 
otherwise treatment-resistant idiopathic pruritus in nine HIV-
infected patients. In view of recent report that a lamp with peak 
emission at 325 nm is superior to PUV A lamp in clearing psoriasis, 
W. Morison (Towson, MD) conducted a bilateral comparison 
study in 10 patients with psoriasis to evaluate whether oral methox-
salen enhanced the effects of UVB phototherapy; no beneficial 
effect was noted in the presence of oral methoxsa.len. J. Hawk 
(London, England) reported the result of PUV A treatment for 
vitiligo in 140 patients over 10 years. Sixty-nine percent of 
patients improved, 28% significantly, and 4% almost completely. 
Seventy-five percent of patients had relapse, 66% occurring 
within 6 months of treatment. 
The last section of the meeting was on therapy. F. Gasparro 
(New Haven, CT) evaluated the photochemistry of 5-metho,,}'-
psora.len (MOP), which is used in Europe. The photochemistry of 
5-MOP was similar to that of 8-MOP; however, the mutagenicity 
of 5-MOP in humans has not been well studied. M. Mathews-Roth 
(Boston, MA) reported the result of a double-blind, cross-over trial 
of oral cysteine in 16 patients with erythropoietic protoporphyria 
(EPP). Photosensitivity was significantly suppressed in cysteine-
treated group, suggesting that cystein may be another treatment 
option for EPP. A. Oseroff (Buffalo, NY) reported the efficacy of 
photodynamic therapy (PDT) using topical o-aminolevulinic acid 
(10-40% in Moisturel lotion) in superficial (but not in nodular) 
basal cell carcinoma and in Bowen's disease. He further reported 
that PDT with Photofri1, was highly effective for basal cell carci-
nomas in patients with Basal Cell Nevus Syndrome. 
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